Bupropion for the Treatment of Methamphetamine Dependence

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-07-31

Study Completion Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the efficacy and safety of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence

NCT00687713

Methamphetamine Dependence

COMPLETED PHASE2

Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2

NCT00135785

Methamphetamine

COMPLETED PHASE2

Study of Medical Treatment for Methamphetamine Addiction

NCT00833443

Methamphetamine Amphetamine Dependence Pharmacogenetics +2 more

COMPLETED PHASE2

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

NCT00040040

Amphetamine-Related Disorders

UNKNOWN PHASE1

A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

NCT00033124

Substance-Related Disorders

UNKNOWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A double-blind, placebo-controlled, parallel-group design study in which 100 subjects will be randomly assigned to placebo or bupropion for 12 weeks with follow-up assessments 4 weeks following treatment. Adaptive randomization will be used to balance treatment groups based on gender.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amphetamine-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupropion

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must have methamphetamine dependence as determined by the DSM-IV diagnosis
* Subject must be willing to comply with study procedures.
* Ability to verbalize understanding of consent form, provide written consent, and verbalize willingness to complete study procedures
* Be able to comply with protocol requirements